Link Biosystems Inc.
Irvington, NY · Biotech · Private
Bioreactor system for scalable expansion of immunocompetent tumoroid tissues from patient tumor samples using defined serum-free media, controlled aggregation, and perfusion culture
- Grants
- $1.8M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Cell Expansion Bioreactors For Assay-ready Immunocompetent Patient Models | $327,767 | |
| Federal grant | Department of Health and Human Services · Phase I · Efficient Differentiation, Scale-up, And Maturation Of Ips Derived Cardiomyocytes | $275,396 | |
| Federal grant | Department of Health and Human Services · Phase I · Efficient Scale-up Of Ips Cells For Autologous Cell Therapy Workflow | $275,627 | |
| Federal grant | Department of Health and Human Services · Phase II · Cell Expansion Bioreactors For Assay-ready Immunocompetent Patient Models | $911,110 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1417 | Omega Biosystems Incorporated | — | — |
| 1418 | Omm Scientific, Inc | — | — |
| 1419 | EVODENOVO INC | — | — |
| 1420 | Link Biosystems Inc. | — | — |
| 1421 | NEUMEDICINES, INC. | — | — |
| 1422 | Rectify Pharmaceuticals LLC | — | — |
| 1423 | MOLECULAR THERANOSTICS, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.